Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study.
Translational andrology and urology（2022）
摘要
This retrospective study demonstrated that orally administered roxadustat improved hemoglobin levels more than rhEPO in patients with CKD and anemia.
更多查看译文
关键词
Roxadustat,anemia,chronic kidney disease (CKD),erythropoietin,propensity-score matching
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要